Matthew Bennett

Matthew Bennett

Directeur Général chez
Enterprise Consulting Solutions, Inc.
54 ans
Health Technology
Technology Services
Commercial Services

Profil

Matthew M.
Bennett
currently works at Enterprise Consulting Solutions, Inc., as President, CEO, Secretary & Director, NuSil Technology LLC, as Director from 2014, Ontario Systems LLC, as Director from 2019, PROFILE Products LLC, as Director from 2021, HealthComp LLC, as Director from 2020, Covaris, Inc., as Director from 2021, Proterris, Inc., as Director from 2017, and Invidia Capital Management, as Partner from 2025.
Mr. Bennett also formerly worked at HealthPort, Inc., as Chief Executive Officer & Director, CIOX Health LLC, as Vice Chairman of the Board from 2016 to 2021, Cytel, Inc., as Director from 2017 to 2021, Bellerophon Therapeutics, Inc., as Director from 2018 to 2021, New Mountain Capital LLC, as Managing Director from 2016 to 2025, Gelest, Inc., as Director from 2017 to 2020, Real Chemistry, Inc., as Director, Alteon Health LLC, as Director from 2016 to 2018, Avantor, Inc., as Director from 2014 to 2017, Becton, Dickinson & Co., as EVP, Chief Business & Chief Administrative Officer from 2003 to 2007, VIASYS Healthcare, Inc., as Chief Administrative Officer & General Counsel in 2007, Ikaria, Inc., as EVP-Global Medical Operations & General Counsel from 2007 to 2015, Morgan, Lewis & Bockius LLP, as Attorney in 2003, Stradley, Ronon, Stevens & Young LLP, as Litigator, and Sparta Systems, Inc., as Board Member from 2018 to 2019.
Mr. Bennett received his undergraduate degree in 1993 from Princeton University and doctorate degree in 1996 from Villanova University School of Law.

Postes actifs de Matthew Bennett

SociétésPosteDébut
Directeur/Membre du Conseil 01/01/2014
Directeur Général -
Directeur/Membre du Conseil 01/11/2020
Directeur/Membre du Conseil 01/09/2019
Directeur/Membre du Conseil 01/01/2021
Directeur/Membre du Conseil 01/04/2017
Directeur/Membre du Conseil 01/12/2021

Anciens postes connus de Matthew Bennett

SociétésPosteFin
Private Equity Investor 01/08/2025
BELLEROPHON THERAPEUTICS, INC. Directeur/Membre du Conseil 01/03/2021
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Matthew Bennett

Formation de Matthew Bennett

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

93

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées24

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Commercial Services

Commercial Services

Process Industries

Technology Services

Consumer Services

Distribution Services

Technology Services

Process Industries

Technology Services

Finance

Health Technology

Commercial Services

Health Services

Consumer Services

Technology Services

Technology Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Matthew Bennett
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇